RRoche Read More Are Biosimilars Becoming a Key Pillar of Amgen’s Growth Story?2026-06-23 Historically known for its innovative biologic medicines such as Enbrel, Prolia and Repatha, AmgenAMGN has also emerged as…
RRoche Read More Will Roche Stock Rebound To Its 2022 Highs of $50?2026-03-29 The stock price of Roche (OTCMKTS: RHHBY) trades at $35 per share, about 33% below its peak level of over…
RRoche Read More Roche’s Genentech Expands Investment in North Carolina Facility to $2B2026-03-18 Swiss pharma giant Roche’s RHHBY Genentech announced a significant expansion of its original investment in a new manufacturing…